Feasibility and Outcome of Cognitive Behavioral Analysis System of Psychotherapy (CBASP) for Chronically Depressed Inpatients: A Pilot Study
2011-01-01

Letters| March 10 2011 Feasibility and Outcome of Cognitive Behavioral Analysis System of Psychotherapy (CBASP) for Chronically Depressed Inpatients: A Pilot Study Subject Area: Psychiatry and Psychology Eva-Lotta Brakemeier; Eva-Lotta Brakemeier aDepartment of Psychiatry and Psychotherapy, University of Freiburg Medical Center, Freiburg, and Search for other works by this author on: This Site PubMed Google Scholar Vera Engel; Vera Engel aDepartment of Psychiatry and Psychotherapy, University of Freiburg Medical Center, Freiburg, and bDepartment of Psychology, University of Tübingen, Tübingen, Germany Search for other works by this author on: This Site PubMed Google Scholar Elisabeth Schramm; Elisabeth Schramm aDepartment of Psychiatry and Psychotherapy, University of Freiburg Medical Center, Freiburg, and Search for other works by this author on: This Site PubMed Google Scholar Ingo Zobel; Ingo Zobel aDepartment of Psychiatry and Psychotherapy, University of Freiburg Medical Center, Freiburg, and Search for other works by this author on: This Site PubMed Google Scholar Teresa Schmidt; Teresa Schmidt aDepartment of Psychiatry and Psychotherapy, University of Freiburg Medical Center, Freiburg, and Search for other works by this author on: This Site PubMed Google Scholar Martin Hautzinger; Martin Hautzinger bDepartment of Psychology, University of Tübingen, Tübingen, Germany Search for other works by this author on: This Site PubMed Google Scholar Mathias Berger; Mathias Berger aDepartment of Psychiatry and Psychotherapy, University of Freiburg Medical Center, Freiburg, and Search for other works by this author on: This Site PubMed Google Scholar Claus Normann Claus Normann aDepartment of Psychiatry and Psychotherapy, University of Freiburg Medical Center, Freiburg, and Search for other works by this author on: This Site PubMed Google Scholar Psychother Psychosom (2011) 80 (3): 191–194. https://doi.org/10.1159/000320779 Article history Received: February 03 2010 Accepted: August 26 2010 Published Online: March 10 2011 Content Tools Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Tools Icon Tools Get Permissions Cite Icon Cite Search Site Citation Eva-Lotta Brakemeier, Vera Engel, Elisabeth Schramm, Ingo Zobel, Teresa Schmidt, Martin Hautzinger, Mathias Berger, Claus Normann; Feasibility and Outcome of Cognitive Behavioral Analysis System of Psychotherapy (CBASP) for Chronically Depressed Inpatients: A Pilot Study. Psychother Psychosom 1 April 2011; 80 (3): 191–194. https://doi.org/10.1159/000320779 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsPsychotherapy and Psychosomatics Search Advanced Search Article PDF first page preview Close Modal © 2010 S. Karger AG, Basel2011Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. You do not currently have access to this content.